Oncternal Therapeutics Correlations

ONCT Stock

USD 0.53 0.16 23.19%

The current 90-days correlation between Oncternal Therapeutics and Vaccinex is 0.02 (i.e., Significant diversification). The correlation of Oncternal Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.

Oncternal Therapeutics Correlation With Market

Good diversification

The correlation between Oncternal Therapeutics and DJI is -0.1 (i.e., Good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Oncternal Therapeutics and DJI in the same portfolio, assuming nothing else is changed.

Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Oncternal Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.

For more information on how to buy Oncternal Stock please use our How to Invest in Oncternal Therapeutics guide.

Moving together with Oncternal Stock

0.81	VALN	Valneva SE ADR	Pair Corr
0.67	VCNX	Vaccinex	Pair Corr
0.66	DTIL	Precision BioSciences Downward Rally	Pair Corr
0.61	VINC	Vincerx Pharma	Pair Corr
0.86	VRAX	Virax Biolabs Group	Pair Corr
0.72	VRCA	Verrica Pharmaceuticals	Pair Corr
0.64	VRPX	Virpax Pharmaceuticals	Pair Corr
0.71	VTGN	VistaGen Therapeutics	Pair Corr

Moving against Oncternal Stock

0.68	VCYT	Veracyte	Pair Corr
0.61	VERA	Vera Therapeutics	Pair Corr
0.49	DMAC	DiaMedica Therapeutics Downward Rally	Pair Corr
0.45	DSGN	Design Therapeutics	Pair Corr
0.4	DRUG	Bright Minds Biosciences Trending	Pair Corr
0.4	SABSW	SAB Biotherapeutics	Pair Corr
0.8	VRDN	Viridian Therapeutics	Pair Corr
0.63	VRNA	Verona Pharma PLC	Pair Corr
0.56	VSTM	Verastem Trending	Pair Corr
0.34	VTRS	Viatris	Pair Corr
0.33	DVAX	Dynavax Technologies	Pair Corr

Related Correlations Analysis

	NLTX	CTMX	ASMB	TIL	NUVB	TARA	VCNX	MNPR	MIRO
NLTX		0.4	0.03	0.38	0.22	-0.52	0.4	-0.5	-0.44	NLTX
CTMX	0.4		0.28	0.39	0.21	-0.72	0.39	-0.82	-0.8	CTMX
ASMB	0.03	0.28		0.12	0.26	-0.02	0.3	-0.13	-0.03	ASMB
TIL	0.38	0.39	0.12		-0.18	-0.41	-0.04	-0.32	-0.55	TIL
NUVB	0.22	0.21	0.26	-0.18		0.17	0.8	-0.11	0.1	NUVB
TARA	-0.52	-0.72	-0.02	-0.41	0.17		-0.09	0.82	0.84	TARA
VCNX	0.4	0.39	0.3	-0.04	0.8	-0.09		-0.29	-0.09	VCNX
MNPR	-0.5	-0.82	-0.13	-0.32	-0.11	0.82	-0.29		0.78	MNPR
MIRO	-0.44	-0.8	-0.03	-0.55	0.1	0.84	-0.09	0.78		MIRO
	NLTX	CTMX	ASMB	TIL	NUVB	TARA	VCNX	MNPR	MIRO

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

MIRO	+ 0.84	TARA
MNPR	+ 0.82	TARA
VCNX	+ 0.8	NUVB
MIRO	+ 0.78	MNPR
CTMX	+ 0.4	NLTX
VCNX	+ 0.4	NLTX

High negative correlations

MNPR	- 0.82	CTMX
MIRO	- 0.8	CTMX
TARA	- 0.72	CTMX
MIRO	- 0.55	TIL
TARA	- 0.52	NLTX
MNPR	- 0.5	NLTX

Risk-Adjusted Indicators

There is a big difference between Oncternal Stock performing well and Oncternal Therapeutics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Oncternal Therapeutics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
NLTX	2.25	(0.11)	0.00	0.34	0.00	0.00	4.05	(3.53)	27.84
CTMX	2.78	(0.24)	0.00	(0.06)	0.00	0.00	6.25	(5.22)	20.61
ASMB	2.92	0.06	0.00	0.32	4.39	(2.87)	8.79	(5.34)	21.34
TIL	9.65	1.55	0.25	0.46	6.97	(12.82)	20.63	(10.89)	105.83
NUVB	3.52	(0.59)	0.00	(0.02)	0.00	0.00	9.48	(8.36)	21.30
TARA	3.34	0.69	0.18	5.54	2.72	(4.49)	8.67	(4.98)	19.48
VCNX	5.98	(0.17)	0.00	(0.23)	0.00	0.00	11.11	(14.00)	54.95
MNPR	20.43	10.98	0.92	(2.33)	7.87	(24.51)	15.93	(9.50)	653.56
MIRO	4.85	0.45	0.05	(3.71)	5.26	(6.37)	11.73	(8.87)	38.49

Oncternal Therapeutics Corporate Management

Pablo Urbaneja	Senior Development	Profile
Anita Wiseth	Senior Resources	Profile
Gunnar Kaufmann	Chief Officer	Profile
Chase JD	General Secretary	Profile
Salim MD	Chief Officer	Profile
Chase Leavitt	General Secretary	Profile
Steven Hamburger	VP Assurance	Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC